©bongkarn thanyakij via Canva.com

Tumor Burden and Clinical Benefit Assessment in Immunotherapy Clinical Trials

Name: Tumor Burden and Clinical Benefit Assessment in Immunotherapy Clinical Trials
Start: 2016-09-19T14:30:00+0000
End: 2016-09-19T15:30:00+0000

This Webinar is over

Date	Sep 19, 2016
Time	10:30 AM EDT
Cost	Free
Online

This webinar will give an overview of endpoint assessment as it relates to RECIST, irRC, and clinical benefit in the setting of cancer immunotherapy. Recommendations on when and how to apply each criterion will be reviewed as will case histories illustrating the clinical decision-making needed to determine if a patient should continue treatment.

Create your own event
Turn your passion into a business.